Previous 10 | Next 10 |
In the days and weeks leading up to the start of the coronavirus pandemic, the S&P 500 index was hitting all-time highs. On Feb. 19 of this year, it achieved a record peak since the Great Recession of 2008, closing at 3,386.15. Then the bottom fell out. By March 23, the S&P 500 ...
Although the coronavirus crisis is far from over, it has already transformed the way healthcare players operate. Some companies have seen record demand for their essential medicines, while others have only recently seen their revenues rebound after shutdowns and stay-at-home orders wreaked havo...
Image source: The Motley Fool. Abiomed Inc (NASDAQ: ABMD) Q1 2021 Earnings Call Aug 6, 2020 , 8:00 a.m. ET Operator Continue reading
The following slide deck was published by Abiomed, Inc. in conjunction with their 2021 Q1 earnings Read more ...
ABIOMED, Inc. (ABMD) Q1 2021 Earnings Conference Call August 06, 2020, 08:00 ET Company Participants Todd Trapp - CFO & VP Michael Minogue - Chairman, CEO & President Conference Call Participants Rajbir Denhoy - Jefferies Margaret Kaczor - William Blair & Compan...
Abiomed (NASDAQ: ABMD ) : Q1 Non-GAAP EPS of $0.58 beats by $0.26 ; GAAP EPS of $0.98 beats by $0.71 . Revenue of $164.85M (-20.6% Y/Y) beats by $20.73M . Press Release More news on: Abiomed, Inc., Earnings news and commentary, Healthcare stocks news,
June Revenue Up 4% Versus Prior Year Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported first quarter fiscal 2021 revenue of $164.9 million compared to revenue of $207.7 million for the same period of fiscal 2020 despite a nega...
The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 patients who are undergoing ECMO treatment and develop pulmonary edema or myocarditis. Impe...
Study conducted at 109 hospitals with oversight by 10 Japanese professional societies, including Japanese Circulation Society A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77% surviv...
Investment Thesis Abiomed 5-year share price performance. Source: TradingView The medical device industry has produced a number of notable share price winners in recent years, owing to advances in technology and the companies that have found ways to apply new technologies to augment or enh...
News, Short Squeeze, Breakout and More Instantly...
Abiomed (Nasdaq: ABMD) announces the United States Food and Drug Administration (FDA) has approved the version of Impella ECP that will be used in the Impella ECP Pivotal Trial, and the first two patients have been enrolled in the trial. Amir Kaki, MD, director of mechanical circulatory support...
Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400 PR Newswire NEW YORK , Dec. 19, 2022 /PRNewswire/ -- S&P MidCap 400 constituent...
Abiomed (Nasdaq: ABMD) announces the first three patients in the world have been treated with Impella RP Flex with SmartAssist, Abiomed’s newest heart pump for patients experiencing right heart failure. All three patients have now been successfully weaned off Impella support and two have...